{"schema_version":"secwatch.filing_event.v1","accession":"0001360604-22-000130","form_type":"8-K","ticker":"HR","cik":"0001360604","company_name":"Healthcare Realty Trust Inc","filed_at":"2022-11-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.322794+00:00","generated_at":"2026-06-22T00:51:03.602162+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Healthcare Realty Trust Q3 normalized FFO $0.39; same-store NOI +2.8%, merger synergies $16.4M","bullets":["Net income $28.3M ($0.08 diluted EPS); normalized FFO $129.4M ($0.39/diluted share).","Same-store cash NOI +2.8% YoY; TTM growth 2.4%. Cash leasing spreads 2.9% on 634K sq ft renewed.","Realized $16.4M annualized G&A synergies (half of $33-36M target); expects remaining $18M over next three quarters.","Closed $922M in JV/asset sales at 4.6% cap rate; expects total >$1.1B at 4.8% cap rate.","Dividend $0.31/share, payable Nov 30 to holders of record Nov 15."],"urls":{"canonical":"https://secwatch.observer/filing/0001360604-22-000130","json":"https://secwatch.observer/filing/0001360604-22-000130.json","markdown":"https://secwatch.observer/filing/0001360604-22-000130.md","text":"https://secwatch.observer/filing/0001360604-22-000130.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1360604/000136060422000130/0001360604-22-000130-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1360604/000136060422000130/hta-20221109.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T00:51:03.602162+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"61146a7b5437124b16ecff34dd31526aee75d660","claim":"Healthcare Realty Trust Inc reported third quarter ended September 30, 2022 results: net income $28.3 million, EPS $0.08 per diluted common share.","evidence_excerpt":"The Company reported net income attributable to common stockholders of $28.3 million, or $0.08 per diluted common share, for the quarter ended September 30, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1360604/000136060422000130/0001360604-22-000130-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"third quarter ended September 30, 2022"},{"label":"Net income","value":"$28.3 million"},{"label":"EPS","value":"$0.08 per diluted common share"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}